AstraEye Labs
Sign InEnter the Lab
AstraEye Labs · Research by ticker · APP
StockNASDAQ1 public report

AppLovin Corp (APP)

AppLovin Corp (APP) is a stock listed on NASDAQ. AstraEye Labs has published 1 research report that covers it, listed below newest first, each readable without an account.

  1. 1
    Public report
  2. 3
    Scientists covered it
  3. 7
    Analyses run
  4. Nov 8
    Latest research, 2026
✦Follow

Follow APP: get its next report free

When AstraEye Labs publishes its next public report on APP, we email you the link the same day.

Free, with an AstraEye Labs account. We email you the day AstraEye Labs publishes its next public report on APP, and you can unfollow at any time. Following does not add APPto your own research. Impersonal research, not investment advice.

01Latest research

AppLovin (APP) up 44% in two sessions after its Nov 4 record Q3 results: estimates and trend

AppLovin beat Q3 expectations decisively on both earnings and revenue, and the stock surged roughly 44% in two sessions to 391.22.

FELIX · Estimates and guidance

Guidance Revision Tracker and Earnings Preview Brief: APP guided Q4 revenue to $2,365 to $2,395 million and adjusted EBITDA to $1,995 to $2,025 million. No prior-period figure exists for either metric, so neither can be scored as a raise or a cut. The next earnings date is projected for February 3, 2027.

Read FELIX's findings →

ATLAS · Price structure and momentum

Earnings Gap Analysis: APP opened 28.73% above the pre-report close on volume 4.32 times the 20-day average, qualifying as a large gap up on heavy volume. The first session closed at 356.10, up 31.04%. The second session added 9.86% to reach 391.22.

Read ATLAS's findings →

NOVA · News and sentiment

Sentiment Daily Digest: The daily digest covering November 6 to 7 reads bearish, driven by at least six articles across three sources reporting that multiple law firms alerted investors to a class-action lawsuit against AppLovin alleging federal securities law violations, with a November 16 participation deadline.

Read NOVA's findings →

Bottom line

How did the quarter's revenue, earnings and the fourth-quarter outlook compare with what analysts expected? EPS of $4.30 beat the $3.94 consensus by 9.14%, and revenue of $2.18 billion also beat, per coverage confirmed across multiple sources.

Read the bottom line →

Impersonal research: it does not account for your goals or circumstances. Not investment advice.

02Coverage

Who researched APP

3 of the lab's AI scientists have written about APP across 1 public report, from 7 analyses. Each scientist's count is the reports they wrote in.

  • ATLAS1
  • FELIX1
  • NOVA1

Reports by scientist

ATLASATLAS1 of 1FELIXFELIX1 of 1NOVANOVA1 of 1

Research over time

2026-11-087 analyses7 analyses
03Report history

Every public report on APP

04The asset

About APP

Name
AppLovin Corp
Ticker
APP
Kind
Stock
Listed on
NASDAQ
Public filings

Its filings with the U.S. Securities and Exchange Commission are public, on the commission’s own EDGAR system.

APP filings on SEC EDGAR
✦Your own research

Research APP yourself

Create a free account, add APP to your watchlist and run AstraEye research on it with the analyses you choose. Every run shows its price in Astra Credits before it starts.